Glucocorticoids Increase Interleukin–6–Dependent Gene Induction by Interfering With the Expression of the Suppressor of Cytokine Signaling 3 Feedback Inhibitor
Open Access
- 2 September 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 55 (1) , 256-266
Abstract
Glucocorticoids are known to be potent regulators of inflammation and have been used pharmacologically against inflammatory, immune, and lymphoproliferative diseases for more than 50 years. Due to their possible and well–documented side effects, it is crucial to understand the molecular mechanisms and targets of glucocorticoid action in detail. Several modes of action have been discussed; nevertheless, none of them fully explain all the functions of glucocorticoids. Therefore, we analyzed the cross–talk between glucocorticoids and interleukin–6 (IL–6) in the liver. IL–6 exerts pro–inflammatory as well as anti–inflammatory properties and is a main inducer of the acute–phase response. The balance between the proinflammatory and anti–inflammatory activities of IL–6 is tightly regulated by suppressor of cytokine signaling 3 (SOCS3), a well–known feedback inhibitor of IL–6 signaling. Here, it is demonstrated that glucocorticoids enhance IL–6–dependent γ–fibrinogen expression. Studying of the underlying mechanism revealed prolonged activation of signal transducer and activator of transcription 3 (STAT3) caused by down–regulation of SOCS3 protein expression. Consequently, in SOCS3–deficient cells glucocorticoids do not affect IL–6–induced signal transduction. Moreover, in hepatocytes lacking the SOCS3 recruiting motif within gp130, IL–6–dependent γ–fibrinogen expression is not influenced by glucocorticoid treatment. Conclusion: Glucocorticoids interfere with IL–6–induced expression of the feedback inhibitor SOCS3, thereby leading to enhanced expression of acute–phase genes in hepatocytes. This mechanism contributes to the explanation of how glucocorticoids affect inflammation and acute–phase gene induction. (Hepatology 2012;55:256–266)Keywords
This publication has 35 references indexed in Scilit:
- Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell functionJournal of Experimental Medicine, 2010
- Lack of Glycoprotein 130/Signal Transducer and Activator of Transcription 3-Mediated Signaling in Hepatocytes Enhances Chronic Liver Injury and Fibrosis Progression in a Model of Sclerosing CholangitisThe American Journal of Pathology, 2010
- Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradationJournal of Cell Science, 2010
- Dual Function of Interleukin-1β for the Regulation of Interleukin-6-induced Suppressor of Cytokine Signaling 3 ExpressionJournal of Biological Chemistry, 2004
- The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signallingBiochemical Journal, 2004
- STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the α2-macroglobulin geneGenes & Development, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoidJournal of Endocrinology, 1998
- Promoter-dependent Synergy between Glucocorticoid Receptor and Stat5 in the Activation of β-Casein Gene TranscriptionJournal of Biological Chemistry, 1997
- Regulation of synthesis and secretion of major rat acute‐phase proteins by recombinant human interleukin‐6 (BSF‐2/1L‐6) in hepatocyte primary culturesEuropean Journal of Biochemistry, 1988